Human papilloma virus (HPV) is recognized as a major cause for cervical cancer among women worldwide. Two HPV vaccines are currently available: Gardasil(®) and Cervarix(®). Both vaccines enclose viral antigenic proteins, but differ as to the biological systems of culture and the adjuvant components. Recently, a collection of symptoms, indicating nervous system dysfunction, has been described after HPV vaccination. We retrospectively described a case series including 18 girls (aged 12-24 years) referred to our "Second Opinion Medical Network" for the evaluation of "neuropathy with autonomic dysfunction" after HPV vaccination. All girls complained of long-lasting and invalidating somatoform symptoms (including asthenia, headache, cognitive dysfunctions, myalgia, sinus tachycardia and skin rashes) that have developed 1-5 days (n = 11), 5-15 days (n = 5) and 15-20 days (n = 2) after the vaccination. These cases can be included in the recently described immune dysfunction named autoimmune/inflammatory syndrome induced by adjuvants (ASIA). HPV vaccine, through its adjuvant component, is speculated to induce an abnormal activation of the immune system, involving glia cells in the nervous system too. Further researches should aim at defining the pathological and clinical aspects of these post-vaccination diseases and identifying a genetic background predisposing to these adverse reactions.

Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature / B. Palmieri, D. Poddighe, M. Vadalà, C. Laurino, C. Carnovale, E. Clementi. - In: IMMUNOLOGIC RESEARCH. - ISSN 0257-277X. - 65:1(2017 Feb), pp. 106-116. [10.1007/s12026-016-8820-z]

Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature

D. Poddighe
Secondo
;
C. Carnovale
Penultimo
;
E. Clementi
Ultimo
2017

Abstract

Human papilloma virus (HPV) is recognized as a major cause for cervical cancer among women worldwide. Two HPV vaccines are currently available: Gardasil(®) and Cervarix(®). Both vaccines enclose viral antigenic proteins, but differ as to the biological systems of culture and the adjuvant components. Recently, a collection of symptoms, indicating nervous system dysfunction, has been described after HPV vaccination. We retrospectively described a case series including 18 girls (aged 12-24 years) referred to our "Second Opinion Medical Network" for the evaluation of "neuropathy with autonomic dysfunction" after HPV vaccination. All girls complained of long-lasting and invalidating somatoform symptoms (including asthenia, headache, cognitive dysfunctions, myalgia, sinus tachycardia and skin rashes) that have developed 1-5 days (n = 11), 5-15 days (n = 5) and 15-20 days (n = 2) after the vaccination. These cases can be included in the recently described immune dysfunction named autoimmune/inflammatory syndrome induced by adjuvants (ASIA). HPV vaccine, through its adjuvant component, is speculated to induce an abnormal activation of the immune system, involving glia cells in the nervous system too. Further researches should aim at defining the pathological and clinical aspects of these post-vaccination diseases and identifying a genetic background predisposing to these adverse reactions.
ADR; ASIA; Adjuvant; Autoimmune syndrome; HPV; Symptoms; Vaccine
Settore BIO/14 - Farmacologia
feb-2017
9-ago-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
1 .pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 235.93 kB
Formato Adobe PDF
235.93 kB Adobe PDF Visualizza/Apri
Palmieri2017_Article_SevereSomatoformAndDysautonomi.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 361.19 kB
Formato Adobe PDF
361.19 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/474219
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 42
social impact